ESC 365 - Anticoagulation in atrial fibrillation: what the trials tell us and gaps in current knowledge.

Open Access

Anticoagulation in atrial fibrillation: what the trials tell us and gaps in current knowledge.

Session: Advances in anticoagulation to improve patient care in atrial fibrillation

Topic: Stroke Prevention

Speaker: Professor R. Lopes (Durham, US)

Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

24 presentations

0 follower

5 more presentations in this session

Evolution in atrial fibrillation patient care for stroke prevention.

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Recent advances in the management of NOACs during interventional procedures.

Speaker: Professor L. Di Biase (The Bronx, US)

Beyond trials: learning from clinical practice.

Speaker: Professor G. Lip (Liverpool, GB)

Better use of scientific evidence in clinical practice.

Speaker: Professor H. Heidbuchel (Antwerp, BE)

The evolving role of NOACs in AF patient care – Q&A.

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Access the full session

Advances in anticoagulation to improve patient care in atrial fibrillation

Speakers: Professor R. Lopes, Professor H. Heidbuchel, Professor L. Di Biase, Professor G. Lip, Professor H. Heidbuchel...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources